Anti-CD257/BAFF/TNFSF13B/BLYS Antibody (SAA2395) from ProteoGenix; catalogue ARO-A22838; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CD257/BAFF/TNFSF13B/BLYS Antibody (SAA2395) is a highly specific and sensitive antibody that targets the CD257/BAFF/TNFSF13B/BLYS protein. This antibody is a valuable tool for researchers in the field of biotechnology, as it plays a crucial role in various biological processes.
The CD257/BAFF/TNFSF13B/BLYS protein is a member of the tumor necrosis factor (TNF) superfamily and is primarily expressed by immune cells such as B cells, T cells, and dendritic cells. This protein is involved in regulating the survival, proliferation, and differentiation of B cells, as well as the maturation of T cells. It also plays a crucial role in the development and maintenance of the immune system.
The Anti-CD257/BAFF/TNFSF13B/BLYS Antibody (SAA2395) is widely used in various research applications, including flow cytometry, immunoprecipitation, and western blotting. It is also suitable for use in immunohistochemistry and functional assays.
This antibody has been successfully used in various experimental studies, including the investigation of the role of CD257/BAFF/TNFSF13B/BLYS in autoimmune diseases, B cell malignancies, and immune system disorders. It has also been used to study the signaling pathways and interactions of this protein with other molecules.
This antibody is highly specific and sensitive, making it an ideal tool for studying the role of CD257/BAFF/TNFSF13B/BLYS in various biological processes. Its wide range of applications and successful use in various experimental studies make it a valuable asset for researchers in the biotechnology field.
ProteoGenix catalogue number ARO-A22838. For research use only.
Target: Tumor necrosis factor ligand superfamily member 13B, B lymphocyte stimulator, BLyS, B-cell-activating factor, BAFF, Dendritic cell-derived TNF-like molecule, TNF- and APOL-related leukocyte expressed ligand 1, TALL-1, CD257, Tumor necrosis factor ligand superfamily member 13b membrane form, Tumor necrosis factor ligand superfamily member 13b soluble form, TNFSF13B, BAFF, BLYS, TALL1, TNFSF20, ZTNF4; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Tumor necrosis factor ligand superfamily member 13B, B lymphocyte stimulator, BLyS, B-cell-activating factor, BAFF, Dendritic cell-derived TNF-like molecule, TNF- and APOL-related leukocyte expressed ligand 1, TALL-1, CD257, Tumor necrosis factor ligand superfamily member 13b membrane form, Tumor necrosis factor ligand superfamily member 13b soluble form, TNFSF13B, BAFF, BLYS, TALL1, TNFSF20, ZTNF4 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
